Clinical Trials
5 trialsNCT02811783 2022-10-28
Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL
Elorac, Inc.
Phase 3 Terminated
NCT03340155 2017-11-13
BioUV2017
Medical University of Graz
Phase NA Unknown
NCT03290989 2017-09-25
PRURITCC
University Hospital, Brest
Completed
NCT01801670 2015-01-27
Impact of Vorinostat on Pruritus Signaling Pathways - Merck Study
Boston University
Withdrawn
NCT00863395 2014-03-31
CTCL
University of Minnesota
Phase 1/2 Terminated